Second quarter 2019


Sanofi delivered solid growth in Q2 2019

Second quarter 2019 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.

Sanofi continued its growth phase with a solid business performance in Q2, driven by Sanofi Genzyme, Sanofi Pasteur and Emerging Markets

Olivier Brandicourt

Chief Executive Officer



Clinical trials appendix

Press release

Q2 2019 income statements, cash flow statements, balance sheet

Q2 2019 net sales by GBU, franchise, geographic region and product

Download infographic

Pre-quarterly results communication